ArticleMed (New York, N.Y.)2023

Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.

Timothée Bruel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.